Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis.

Schizophrenia research - 1 Nov 2022

Chaumette Boris, Sengupta Sarojini M, Lepage Martin, Malla Ashok, Iyer Srividya N, Kebir Oussama, Dion Patrick A, Rouleau Guy A, Krebs Marie-Odile, Shah Jai L, Joober Ridha

Abstract excerpt

Schizophrenia is an illness characterized by positive symptoms, negative symptoms, and cognitive impairments. Cognitive impairments occur before the onset of psychosis and could reflect glutamatergic dysregulation. Thus, identifying associations between genetic variations in genes coding for glutamatergic receptors and cognitive impairment in schizophrenia may help in understanding the basis of these deficits and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cognition
Share to Cognitive Dysfunction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutamates

Share to Neuropsychological Tests

Share to Polymorphism, Single Nucleotide

Share to Psychotic Disorders

Share to Receptors, Metabotropic Glutamate

Source

Identifiers

PMID: 32624350
DOI: 10.1016/j.schres.2020.06.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis.PMID 32624350Read ↗

Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia.Semantic proximity Read ↗

Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes.Semantic proximity Read ↗

Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia.Semantic proximity Read ↗

Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.Semantic proximity Read ↗

Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia.Semantic proximity Read ↗

Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.Semantic proximity Read ↗

Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia.Semantic proximity Read ↗

The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males.Semantic proximity Read ↗

Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.Semantic proximity Read ↗

Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137.Semantic proximity Read ↗

Influence of DAOA and RGS4 genes on the risk for psychotic disorders and their associated executive dysfunctions: A family-based study.Semantic proximity Read ↗

Rare Copy Number Variants Are Associated With Poorer Cognition in Schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.